NanoViricides, Inc. NNVC
AMEX
| 06/30/2026 | 03/31/2026 | ||||
|---|---|---|---|---|---|
| Revenue | -- | -- | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -- | -- | |||
| Cost of Revenue | -- | -- | |||
| Gross Profit | -- | -- | |||
| SG&A Expenses | 25.80% | -33.22% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 10.64% | -9.09% | |||
| Operating Income | -10.64% | 9.09% | |||
| Income Before Tax | -11.77% | 10.42% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | -11.77% | 10.42% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -11.77% | 10.42% | |||
| EBIT | -10.64% | 9.09% | |||
| EBITDA | -11.36% | 9.50% | |||
| EPS Basic | -8.47% | 17.69% | |||
| Normalized Basic EPS | -8.52% | 17.74% | |||
| EPS Diluted | -8.47% | 17.69% | |||
| Normalized Diluted EPS | -8.52% | 17.74% | |||
| Average Basic Shares Outstanding | 2.99% | 8.86% | |||
| Average Diluted Shares Outstanding | 2.99% | 8.86% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||